Last reviewed · How we verify

Fluoxacillin (FLOXACILLIN)

FDA-approved active Small molecule Quality 19/100

Fluoxacillin (generic name: FLOXACILLIN) is a floxacillin drug. It is currently FDA-approved.

At a glance

Generic nameFLOXACILLIN
Drug classfloxacillin
TargetMatrix metalloproteinase-9, Androgen receptor, Penicillin-binding protein 1A
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fluoxacillin

What is Fluoxacillin?

Fluoxacillin (FLOXACILLIN) is a floxacillin drug.

What is the generic name of Fluoxacillin?

FLOXACILLIN is the generic (nonproprietary) name of Fluoxacillin.

What drug class is Fluoxacillin in?

Fluoxacillin belongs to the floxacillin class. See all floxacillin drugs at /class/floxacillin.

What development phase is Fluoxacillin in?

Fluoxacillin is FDA-approved (marketed).

What does Fluoxacillin target?

Fluoxacillin targets Matrix metalloproteinase-9, Androgen receptor, Penicillin-binding protein 1A and is a floxacillin.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing